Oversupply pressures vitamin prices
Global vitamin markets remain under pressure as prices for key products like Vitamin E 50%, Vitamin A 1000, and D-Calpan continue to decline or hold weak. Despite tight availability for Vitamin D3 500, most other vitamins face oversupply and cautious Q3 contracting. With BASF still absent from the market and limited buying activity, sentiment remains subdued across regions.
In partnership with Feed Additive Prices
Vitamin E 50%
The same pattern is seen this week in most regions, with again a slight decline in prices. There remains no update from BASF regarding the resumption of their vitamin business or the lifting of the force majeure. Despite several maintenance announcements from Chinese manufacturers scheduled for the upcoming period, the market remains relatively weak. Buyers have secured enough contracts for a portion of Q3.
Vitamin A 1000
The prevailing market trend continues to show a gradual decline in prices across all major regions. BASF has previously stated that production of vitamin A1000 was expected to resume in April 2025; however, there have yet to be any indications of their market return or the lifting of force majeure. Supply remains plentiful while demand appears restrained, and only a portion of Q3 is contracted.
Vitamin D3 500
Prices are mostly stable, but still at a relatively high level. Sometimes there are signs of some decline, but nothing significant. Overall, prices remain very high and availability is tight in most regions. A considerable portion of Q3 contracts has already been finalised.
D-Calpan
The market continues to show a stable to weak tone and lack of trading activity in most areas, with prices remaining low. It seems there is too much material and capacity available, leading to sales pressure in all major regions. At present, only a portion of Q3 has been secured, reflecting a careful approach among buyers.
Vitamin B3
Mostly a stable market at low price levels. Some suppliers are keen to move volume and offer even lower prices, but as the market is relatively well covered, it does not lead to actual transactions. Buyers currently have a wait-and-see attitude. Only a portion of Q3 has been contracted.
